Comparison of perspectives on prostate cancer: Analyses of survey data

Urology

Volumn 50, Issue 3, 1997, Pages 366-372

  Crawford, E David ^b   Bennett, Charles L ^a   Stone, Nelson N ^b   Knight, Sara J ^b   DeAntoni, Edward ^b   Sharp, Lisa ^b   Garnick, Marc B ^b   Porterfield, Henry A ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; DATA ANALYSIS; DECISION MAKING; HEALTH CARE COST; HEALTH CARE NEED; HEALTH CARE POLICY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PATIENT EDUCATION; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; UROLOGY;

AGED; DATA COLLECTION; EMOTIONS; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION; PATIENT SATISFACTION; PHYSICIAN-PATIENT RELATIONS; PROSTATIC NEOPLASMS; QUALITY OF LIFE;

EID: 0030773354     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00254-9     Document Type: Article

References (27)

1. American Cancer Society: Cancer Facts & Figures -1997. Atlanta, American Cancer Society, 1996.
2. Parker SL, Tong T, Bolden S, and Wingo PA: Cancer statistics 1997. CA Cancer J Clin 46: 6-27, 1997.
3. Miller BA, Ries Gloeckler LA, Honkey BF, Kosary CL, Fever EJ, Boring CC, and Edwards BK: (Eds): Cancer Statistics Review 1973-1989. NIH publication No. 92-2789. Bethesda, MD, National Cancer Institute, 1992, pp 11-13.
4. Auchincloss SS: Sexual dysfunction in cancer patients, issues in evaluation and treatment, in Rowland JCHaJH (Ed): Handbook of Psychooncology. New York, Oxford University Press, 1989, pp 383-413.
5. Herr HW, Kornblith AB, and Ofman UA: A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy. Cancer 71(suppl): 1143-1150, 1993.
6. Ofman US, and Auchincloss SS: Sexual dysfunction in cancer patients. Curr Opin Oncol 4: 606-613, 1992.
7. Fleming C, Wasson JH, Albertsen PC, Barry NJ, and Wennberg JE: A decision analysis of alternative treatment strategies for clinically localized prostate cancer. JAMA 269: 2650-2658, 1993.
8. Braslis KG, Santa-Cruiz C, Brickman AL, and Soloway MS: Quality of life 12 months after radical prostatectomy. Br J Urol 75: 48-53, 1995.
9. Litwin MS, Hays RD, Fink A, Ganz A, Leake B, Leach GE, and Brook RH: Quality of life outcomes in men treated for localized prostate cancer. JAMA 273: 129-135, 1995.
10. Cassileth BR, Soloway MS, Vogelzang NJ, Chou JM, Schellhammer PD, Seidmon EJ, and Kennealey GT, for the Zoladex Prostate Cancer Study Group: Quality of life and psychosocial status in stage D prostate cancer. Qual Life Res 1: 323-329, 1992.
11. Fossa SD, Aaronson NK, Newling D, Van Congh PJ, Denis L, Kurth KH and De Pauw M: Quality of life and treatment of hormone resistant metastatic prostatic cancer. Eur J Cancer 12: 1133-1136, 1990.
12. Tannock I, Gospodarowicz M, Meakin W, Stewart L, and Rider W: Treatment of metastatic prostatic cancer with low-dose prednisone: evaluation of pain and quality of life as pragmatic indices of response. J Clin Oncol 7: 590-597, 1989.
13. Garnick MB: The dilemmas of prostate cancer. Sci Am 270: 72-81, 1984.
14. Garnick MB: Prostate cancer: screening, diagnosis, and management. Ann Intern Med 118: 804-818, 1993.
15. Kaps EC: The role of the cancer support group, "US TOO." Cancer 74(suppl): 2188-2189, 1994.
16. Iglehart JK: The struggle to reform Medicare. N Engl J Med 334: 1071-1075, 1996.
17. Kemper TF, Mulley AG, and Wennberg JE: Developing decision making programs to improve the quality of health care. Qual Rev Bull 18: 183-190, 1992.
18. Barry MJ, Fowler FJ, Henderson JV Jr, and Wennberg JE: Patient response to a program designed to facilitate patient participation in treatment decisions for benign prostatic hyperplasia. Med Care 33: 771-782, 1995.
19. Wilt TJ, and Brawer MK: Early intervention or expectorant management for prostate cancer. PIVOT: a randomized trial comparing radical prostatectomy with expectorant management for the treatment of clinically localized prostate cancer. Semin Urol 13: 130-136, 1995.
20. Wilt TJ, and Brawer MK: PIVOT: A randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer. J Urol 152: 1910-1914, 1994.
21. Kornblith AB, Herr HW, Hoffman US, Scher HI, and Holland JC: Quality of life of patients with prostate cancer and their spouses: the value of a data base in clinical care. Cancer 73: 2791-2792, 1994.
22. Helgason AR, Fredrikson M, Adolfsson J, and Steineck G: Decreased sexual capacity after external radiation therapy for prostate cancer impairs quality of life. Int J Radiat Oncol Biol Phys 32: 33-39, 1995.
23. Schover LR: Sexual rehabilitation after treatment for prostate cancer. Cancer 71(suppl): 1024-1030, 1993.
24. Mettlin CJ, and Murphy G: The national cancer data base report on prostate cancer. Cancer 74: 1640-1648, 1994.
25. Deans G, Bennett-Emslie GB, Weir J, Smith DC, and Kaye SB: Cancer support groups - who joins and why? Br J Cancer 58: 670-674, 1988.
26. Taylor SE, Falke RL, Shoptaw SJ, and Lichtman RR: Social support, support groups and the cancer patients. J Consult Clin Psychol 54: 608-615, 1986.
27. Ullman M, Metzger CK, Kuzel T, and Bennett CL: Performance measurement in prostate cancer care. Urology 47: 356-365, 1996.